Table 2.
Clinical characteristics of children treated with heparin and citrate.
| Citrate | Heparin | P | |
|---|---|---|---|
| Median (IQR) | Median (IQR) | ||
| Age (months) | 36.0 (5.6–103.7) | 33.0 (5.6–84.0) | 0.882 |
| Weight | 13.4 (6.8–28.8) | 9.8 (6.3–19.8) | 0.585 |
| PRISM (% of mortality) | 12.6 (3.4–20.8) | 10.0 (6.4–31.4) | 0.716 |
| PIM (% of mortality) | 16.6 (6.9–22.6) | 10.6 (5.5–20.4) | 0.431 |
| MOF | 3 (3–3.75) | 3 (3-4) | 0.681 |
| PELOD (% of mortality) | 11 (11–21) | 21 (12.25–22) | 0.145 |
| Lactic acid | 2.5 (1.3–6.8) | 1.4 (1.0–2.4) | 0.075 |
| Inotropic score | 40 (18–54) | 38 (4–53) | 0.540 |
| Mechanical ventilation | 91.7% | 81.8% | 0.635 |
| Mortality | 25% | 25% | 1.000 |
IQR: interquartile range. MOF: multiorgan failure.